Søgeresultater - Melissa Rowe
- Showing 1 - 6 results of 6
-
1
-
2
Telomouse—a mouse model with human-length telomeres generated by a single amino acid change in RTEL1 af Riham Smoom, Catherine Lee May, Vivian Ortiz, Mark Tigue, Hannah M. Kolev, Melissa Rowe, Yitzhak Reizel, Ashleigh Morgan, Nachshon Egyes, Dan Lichtental, Emmanuel Skordalakes, Klaus H. Kaestner, Yehuda Tzfati
Udgivet 2023Artigo -
3
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma af Loretta J. Nastoupil, Georg Heß, Miguel Arturo Pavlovsky, Iwona Danielewicz, Jane A. Freeman, Alejandro Martı́n, Valeria Glazunova, Andrew Grigg, Jing‐Zhou Hou, Ann Janssens, Seok Jin Kim, Zvenyslava Masliak, Pam McKay, Francesco Merli, Wataru Munakata, Hirokazu Nagai, Muhıt Özcan, Meir Preis, Tingyu Wang, Melissa Rowe, Monelle Tamegnon, Rui Qin, Todd Henninger, Madeliene Curtis, Donne Bennett Caces, Catherine Thiéblemont, Gilles Salles
Udgivet 2023Artigo -
4
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS study af Saad Z. Usmani, Thierry Façon, Vânia Hungria, Nizar J. Bahlis, Christopher P. Venner, Marc Braunstein, Luděk Pour, Josep Martí, Supratik Basu, Yaël Cohen, Morio Matsumoto, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Wojciech Legieć, Meral Beksaç, Ângelo Maiolino, Hiroyuki Takamatsu, Aurore Perrot, Mehmet Turgut, Tahamtan Ahmadi, Weiping Liu, Jianping Wang, Katherine Chastain, Jessica Vermeulen, Maria Krevvata, Lorena Lopez-Masi, Jodi Carey, Melissa Rowe, Richard G. Carson, Sonja Zweegman
Udgivet 2025Artigo -
5
Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized pha... af Saad Z. Usmani, Thierry Façon, Vânia Hungria, Nizar J. Bahlis, Christopher P. Venner, Marc Braunstein, Luděk Pour, Josep Martí, Supratik Basu, Yaël Cohen, Morio Matsumoto, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Wojciech Legieć, Meral Beksaç, Ângelo Maiolino, Hiroyuki Takamatsu, Aurore Perrot, Mehmet Turgut, Tahamtan Ahmadi, Weiping Liu, Jianping Wang, Katherine Chastain, Jessica Vermeulen, Maria Krevvata, Lorena Lopez-Masi, Jodi Carey, Melissa Rowe, Richard G. Carson, Sonja Zweegman
Udgivet 2025Errata/Corrigenda -
6
Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results af Jill Corre, Laure Vincent, Philippe Moreau, Benjamin Hébraud, Cyrille Hulin, Marie C. Béné, Annemiek Broijl, Denis Caillot, Michel Delforge, Thomas Dejoie, Thierry Façon, Jérôme Lambert, Xavier Leleu, Margaret Macro, Aurore Perrot, Sonja Zweegman, Thomas Filleron, Bastien Cabarrou, Niels W.C.J. van de Donk, Sabrina Mahéo, Winnie Hua, Jianping Wang, Maria Krevvata, Véronique Vanquickelberghe, Carla de Boer, Alba Tuozzo, Fredrik Borgsten, Melissa Rowe, Richard G. Carson, Soraya Wuillème, Pieter Sonneveld
Udgivet 2025Artigo
Søgeredskaber:
Relaterede emner
Internal medicine
Medicine
Oncology
Bortezomib
Daratumumab
Multiple myeloma
Clinical endpoint
Confidence interval
Gastroenterology
Hazard ratio
Lenalidomide
Surgery
Adverse effect
Alternative medicine
Bendamustine
Biology
Bone marrow
Cancer
Cancer cell
Cancer research
Chemistry
Chemoimmunotherapy
Chemotherapy
Chronic lymphocytic leukemia
Clinical trial
Cyclophosphamide
DNA
Dexamethasone
Effector
Follicular lymphoma